Ginkgo biloba cell suspension cultures were used to bioconvert sinenxan A, 2α, 5α, 10β, 14β-tetra-acetoxy-4 (20), 11-taxadiene, a taxoid isolated from callus tissue cultures of Taxus spp. Besides two major products, 9α-hydroxy-2α, 5α, 10β, 14β-tetra-acetoxy-4 (20), 11-taxadiene 1 and 9α, 10β-dihydroxy-2α, 5α, 14β-triacetoxy-4 (20), 11-taxadiene 2, additional six minor products were obtained and five of them identified as new compounds. On the basis of chemical and spectral data, their structures were identified as 9α,14β-dihydroxy2α, 5α, 10β-triacetoxy-4 (20), 11-taxadiene 3, 6α, 10β-dihydroxy-2α, 5α, 14β-triacetoxy-4 (20), 11-taxadiene 4, 6α, 9α, 10β-trihydroxy2α, 5α, 14β-triacetoxy-4 (20), 11-taxadiene 5, 9α, 10β-O-(propane-2, 2-diy1)-2α, 5α, 14β-triacetoxy-4 (20), 11-taxadiene 6, 9α-hydroxy2α, 5α, 10β, 14β-tetra-acetoxy-4 (20), 11-taxadiene formate 7, 10β-hydroxy-2α, 5α, 9α, 14β-tetra-acetoxy-4 (20), 11-taxadiene formate 8, respectively. Investigation of the properties of the enzymes responsible for the biocatalysis process of sinenxan A to 1 and 2 revealed that the enzymes were extracellular and constitutive. Using sinenxan A and the two major products (1 and 2) as indicators, the stage and concentration of sinenxan A added and the kinetics of the biotransformation reaction were investigated. The results showed that: (1) the optimal stage for sinenxan A addition was the logarithmic phase of the cell growth period, in which sinenxan A was almost completely bioconverted, and the biotransformation rates were up to 60 and 20% for 1 and 2, respectively; (2) the optimal concentration of sinenxan A added was 60mg/L; (3) the substrate was mainly converted into 1 and 2 in the first 48h after addition and then into the minor products.